2024年版日本《甲状腺肿瘤诊疗指南》外科治疗部分更新解读  

Interpretation of surgical update in 2024 Japanese clinical practice guidelines for thyroid tumors

作　　者：张大林[1] 董文武[1] 张浩[1] ZHANG Da-lin;DONG Wen-wu;ZHANG Hao(Department of Thyroid Surgery,the First Hospital of China Medical University,Shenyang 110001,China)

机构地区：[1]中国医科大学附属第一医院甲状腺外科,辽宁沈阳110001

出　　处：《中国实用外科杂志》2025年第1期42-47,共6页Chinese Journal of Practical Surgery

基　　金：辽宁省应用基础研究计划项目(No.2022020225JH2/1013);辽宁省教育厅高校基本科研项目计划(No.LJ242410159046);辽宁省教育厅基本科研项目(No.LJKMZ20221175)。

摘　　要：随着全球甲状腺癌发病率逐年上升,国内外颁布众多指南不断更新,旨在规范甲状腺癌诊疗。日本继2010年10月和2018年12月发布第一和第二版《甲状腺肿瘤诊疗指南》之后,于2024年4月正式发布第三版指南。日本指南从自身的临床实践出发提出问题,以该国的循证医学证据为主做出推荐,值得借鉴和学习。新版指南外科治疗部分推荐意见更加细化、手术策略趋于保守、更注重手术安全管理和功能保护。With the global incidence rate of thyroid cancer rising year by year,many guidelines have been issued and updated at home and abroad to standardize the diagnosis and treatment of thyroid cancer.After the release of the first and second editions of the“Guidelines for the Diagnosis and Treatment of Thyroid Tumors”in October 2010 and December 2018,Japan officially released the third edition of the guidelines in April 2024.The Japanese guidelines raise questions based on their own clinical practice and make recommendations based on their own evidence-based medicine,which is worth learning from and emulating.The recommendations for surgical treatment in the new version of the guidelines are more refined,surgical strategies tend to be conservative,and there is a greater emphasis on surgical safety management and functional protection.

关 键 词：甲状腺肿瘤 指南 风险分层 手术并发症 功能保护 循证医学 个体化治疗 

分 类 号：R6[医药卫生—外科学]